FdaApplication
NDA 221104
Identifiers
- fda_app_no: NDA221104
Properties
| Property | Value |
|---|---|
| applicant_name | GILEAD SCIENCES INC |
| application_type | NDA |
| approval_date | 2026-08-27 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BIXLENVO | BICTEGRAVIR SODIUM; LENACAPAVIR SODIUM | EQ 75MG BASE;EQ 50MG BASE | TABLET;ORAL |
1 product